News

Article

Sterility Concerns Cause Recall

Wells Pharmacy Network is voluntarily recalling all of its products due to sterility concerns.

On Sept. 20, 2016, Wells Pharmacy Network announced it was voluntarily recalling all of its sterile human and veterinary products prepared between Feb. 22, 2016 and Sept. 14, 2016 because of FDA concerns regarding a lack of sterility assurance. The company states that no adverse events have been reported as of Sept. 20, 2016.

The company is advising patients and providers to discontinue use of the recalled products and contact the company regarding the return of unused products. Adverse events in humans can be reported through FDA’s MedWatch webpage. Animal adverse events can be reported to FDA on their veterinary safety report page. The company’s press release includes a list of all recalled products.

Source: FDA

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Simona Guidi, Associate Director, ProPharma
Tore Bergsteiner
Behind the Headlines, Episode 20: CAR-T Milestones, Abbvie and Eli Lilly M&A Moves, and More